おかえりなさい
Click “ログイン” to agree to Cointime’s 利用規約 and acknowledge that Cointime’s プライバシーポリシー applies to you.
アカウント登録
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">利用規約</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">プライバシーポリシー</a> applies to you.
siteでログインする
siteで登録する
あなたのメールアドレス
受信トレイを確認する
Click the link we sent to to sign in.
Click the link we sent to to sign up.
Yaotang Biology
company
About
Yaotang Bio is a biotechnology company focusing on combining LNP delivery and gene editing technology.
Highlights
Details
- Last Funding Type
- Angel
- Industries
- Biopharma,Biotechnology
- Founded date
- Jul 1, 2021
- Operating Status
- Active
Yaotang (Shanghai) Biotechnology is a high-tech biotechnology company focusing on developing a new generation of mRNA drugs and gene editing drugs by combining mRNA in vivo delivery technology and gene editing technology. Through the continuous development and optimization of CRISPR, base editing and other new-generation gene editing tools, and innovative improvements to the next-generation mRNA production platform and lipid nanocarrier assembly process, Yaotang Bio is committed to developing treatments for genetic diseases and cardiovascular disease.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
—
Yaotang Biology has raised a total of
—
in funding over 2 rounds. Their latest funding was raised on
Feb 25, 2022 from a Angel round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Feb 25, 2022 | Angel | — | 1 |
|
— | Detail |
Investors
Number of Lead Investors
Number of Investors
1
1
Yaotang Biology is funded by 1 investors.
Xianfeng Qiyun
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
|
Yes | Angel |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
